Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN)

CAPS Rating: 3 out of 5

A biopharmaceutical company committed to improving the lives of people with diabetes, obesity and other diseases through the discovery, development and commercialization of innovative medicines.

Recs

0
Player Avatar gabeb1985 (32.69) Submitted: 10/25/2010 10:16:45 AM : Outperform Start Price: $11.51 AMLN Score: +113.14

Self Explanatory.

Featured Broker Partners


Advertisement